|
NDC00029-6571-26
|
6505-01-312-9086
|
Ticarcillin And Clavulanic Acid |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-6571-26
|
6505-01-312-9086
|
Ticarcillin And Clavulanic Acid |
Veterans Health
|
|
Quote
|
|
TIMENTIN
|
6505-01-312-9086
|
Ticarcillin And Clavulanic Acid |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-6571-26
|
6505-01-312-9086
|
Ticarcillin And Clavulanic Acid |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC000069-2650-6
|
6505-01-312-9872
|
Usp Nifedipine Capsules |
Pfizer Inc.
|
|
Quote
|
|
NDC00069-2670-66
|
6505-01-313-0038
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
1502
|
6505-01-313-0038
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
PROCARDIA XL
|
6505-01-313-0038
|
Nifedipine Extended-release Tabl |
Pfizer Inc.
|
|
Quote
|
|
07602
|
6505-01-313-1823
|
Prochlorperazine Edisylate Injec |
Solopak Medical Products Inc
|
|
Quote
|
|
NDC39769-0076-02
|
6505-01-313-1823
|
Prochlorperazine Edisylate Injec |
Solopak Medical Products Inc
|
|
Quote
|
|
NDC51279-1896-20
|
6505-01-313-3704
|
Nifedipine Extended-release Tabl |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0400-20
|
6505-01-313-3705
|
Nifedipine Extended-release Tabl |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00093-9433-05
|
6505-01-313-3707
|
Usp Glyburide Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
F89I014
|
6505-01-313-4839
|
Podophyllum Resin Topical Soluti |
Air Force Medical Logistics Office
|
|
Quote
|
|
PODOFIN
|
6505-01-313-4839
|
Podophyllum Resin Topical Soluti |
Syosset Laboratories Inc
|
|
Quote
|
|
NDC47854-0556-17
|
6505-01-313-4839
|
Podophyllum Resin Topical Soluti |
Syosset Laboratories Inc
|
|
Quote
|
|
CUD2920
|
6505-01-313-6244
|
Usp Isosorbide Dinitrate Tablets |
Armco Medical Supply Inc
|
|
Quote
|
|
A89I262
|
6505-01-313-6246
|
Fluphenazine Hydrochloride Table |
Department of the Army
|
|
Quote
|
|
PROLIXIN
|
6505-01-313-6246
|
Fluphenazine Hydrochloride Table |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0863-50
|
6505-01-313-6246
|
Fluphenazine Hydrochloride Table |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0863-50
|
6505-01-313-6246
|
Fluphenazine Hydrochloride Table |
Squibb E R and Sons Inc
|
|
Quote
|
|
HYTRIN
|
6505-01-313-6820
|
Terazosin Hydrochloride Capsules |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-3805-11
|
6505-01-313-6820
|
Terazosin Hydrochloride Capsules |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00019-1323-21
|
6505-01-313-8361
|
Ioversol And Iodine For Injectio |
Envirovac Inc
|
|
Quote
|
|
NDC00019-1323-11
|
6505-01-313-9548
|
Ioversol And Iodine For Injectio |
Envirovac Inc
|
|
Quote
|
|
TRILAFON
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
16300
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-1865-01
|
6505-01-314-0761
|
Usp Perphenazine Tablets |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00641-0482-25
|
6505-01-314-1155
|
Phenylephrine Hydrochloride Inje |
Elkins-sinn Inc
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Veterans Health
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Astra Pharmaceutical Products Inc
|
|
Quote
|
|
NDC00186-0742-31
|
6505-01-314-2716
|
Omeprazole Extended-release Caps |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC51079-0007-20
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00186-0742-28
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Astra Pharmaceutical Products Inc
|
|
Quote
|
|
NDC66685-0422-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Bristol-myers Co
|
|
Quote
|
|
NDC00186-0742-82
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00006-0727-28
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC60505-0065-02
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
NDC00378-6150-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC62175-0118-37
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Kremers Urban Llc
|
|
Quote
|
|
NDC00904-5684-61
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
NDC51079-0007-30
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mylan Pharmaceuticals Inc.
|
|
Quote
|
|
NDC68084-0128-01
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Amerisource Health Services
|
|
Quote
|
|
NDC63739-0358-10
|
6505-01-314-2717
|
Omeprazole Extended-release Caps |
Mckesson Pharmacy Systems, Llc
|
|
Quote
|
|
9182-01
|
6505-01-314-2737
|
Nf Chloroform |
Avantor Performance Materials, Inc.
|
|
Quote
|
|
A89I208
|
6505-01-314-2737
|
Nf Chloroform |
Department of the Army
|
|
Quote
|
|
ESOPHO-CAT
|
6505-01-314-2738
|
Barium Sulfate Cream |
E-z-em Inc
|
|
Quote
|
|
738
|
6505-01-314-2738
|
Barium Sulfate Cream |
E-z-em Inc
|
|
Quote
|
|
TOPICORT
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
TOPICORT OINTMENT
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC51672-1262-01
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC51672-5203-01
|
6505-01-314-2740
|
Usp Desoximetasone Ointment |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
PLATINOL-AQ
|
6505-01-314-4270
|
Cisplatin Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-3220-22
|
6505-01-314-4270
|
Cisplatin Injection |
Mead Johnson & Company, Llc
|
|
Quote
|
|
3400957615772
|
6505-01-314-4270
|
Cisplatin Injection |
Accord Healthcare France Sas
|
|
Quote
|
|
CYTOSAR-U
|
6505-01-314-4278
|
Usp Cytarabine |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0373-01
|
6505-01-314-4278
|
Usp Cytarabine |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00364-2467-53
|
6505-01-314-4278
|
Usp Cytarabine |
Schein Pharmaceutical Inc
|
|
Quote
|
|
ROCEPHIN ADDVANTAGE
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1965-05
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1965-05
|
6505-01-314-4279
|
Usp Ceftriaxone Sodium |
Cardinal Health 100 Inc
|
|
Quote
|
|
ROCEPHIN
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
ROCEPHIN ADDVANTAGE
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1964-05
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
74521
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1964-05
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00409-7333-04
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
ADD-VANTAGE
|
6505-01-314-4280
|
Usp Ceftriaxone Sodium |
Hospira, Inc.
|
|
Quote
|
|
SENSORCAINE
|
6505-01-314-5852
|
Bupivacaine Hydrochloride Inject |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00186-1033-02
|
6505-01-314-5852
|
Bupivacaine Hydrochloride Inject |
Astra Pharmaceuticals Lp
|
|
Quote
|
